Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Apr 16, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $18.72
Apr 16, 2018
Director
Director Other acquisition or disposition -- --
Apr 16, 2018
Director
Director Other acquisition or disposition -- --
Apr 16, 2018
Director
Director Other acquisition or disposition -- --
Apr 16, 2018
Director
Director Other acquisition or disposition -- --
Apr 16, 2018
Director
Director Other acquisition or disposition -- --
Apr 11, 2018
Director
Director Other acquisition or disposition -- --
Apr 11, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $20.30
Apr 11, 2018
Director
Director Other acquisition or disposition -- --
Apr 11, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $20.72
Apr 11, 2018
Director
Director Other acquisition or disposition -- --
Apr 11, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $19.93
Apr 11, 2018
Director
Director Other acquisition or disposition -- --
Apr 11, 2018
Director
Director Other acquisition or disposition -- --
Apr 11, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Open market or private sale of non-derivative or derivative security 12,300 $15.01
Apr 06, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.74
Apr 06, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Other acquisition or disposition -- --
Apr 06, 2018
Director
Director Open market or private sale of non-derivative or derivative security 3,686 $15.00
Apr 03, 2018
Director
Director Other acquisition or disposition -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.